Suppression of Notch Signaling in Osteoclasts Improves Bone Regeneration and Healing

Peeyush N. Goel,Yasaman Moharrer,John H. Hebb,Alexander J. Egol,Gurpreet Kaur,Kurt D. Hankenson,Jaimo Ahn,Jason W. Ashley
DOI: https://doi.org/10.1002/jor.24384
2019-06-24
Journal of Orthopaedic Research
Abstract:<p>Owing to the central role of osteoclasts in bone physiology and remodeling, manipulation of their maturation process provides a potential therapeutic strategy for treating bone diseases. To investigate this, we genetically inhibited the Notch signaling pathway in the myeloid lineage, which includes osteoclast precursors, using a dominant negative form of MAML (dnMAML) that inhibits the transcriptional complex required for downstream Notch signaling. Osteoclasts derived from dnMAML mice showed no significant differences in early osteoclastic gene expression compared to the wild type. Further, these demonstrated significantly lowered resorption activity using bone surfaces while retaining their osteoblast stimulating ability using <i>ex vivo</i> techniques. Using <i>in vivo</i> approaches, we detected significantly higher bone formation rates and osteoblast gene expression in dnMAML cohorts. Further, these mice exhibited increased bone/tissue mineral density compared to wild type and larger bony calluses in later stages of fracture healing. These observations suggest that therapeutic suppression of osteoclast Notch signaling could reduce, but not eliminate, osteoclastic resorption without suppression of restorative bone remodeling and, therefore, presents a balanced paradigm for increasing bone formation, regeneration, and healing.</p><p>This article is protected by copyright. All rights reserved.</p>
orthopedics
What problem does this paper attempt to address?